Avacta Group PLC - Yorkshire-based drug and medical equipment maker - Lateral flow test for Covid-19 is shown to have 98% sensitivity in clinical study. 20-minute AffiDX test correctly identified 96 out of 98 positive samples of virus and 101 out of 102 negative samples. Test effective on a range of viral loads. Company will file for a CE mark in May and start commercial roll-out in coming months.
Current stock price: 261.69 pence, up 12% on Tuesday
Year-to-date change: more than doubled from 114p on December 31
By Ivan Edwards; firstname.lastname@example.org
Copyright 2021 Alliance News Limited. All Rights Reserved.